I suppose that Anavex could sit on the AD NDA while the Rett submission is in the works but I think that would create a lot of backlash from investors.
Unless you switch out a lagging CRO for the Ph 3 AD trial data scrub. :)
"I suppose that Anavex could sit on the AD NDA while the Rett submission is in the works but I think that would create a lot of backlash from investors."
Which would be very much a "Missling thing" to do.. :D